活跃的情况下
Available by prescription and over-the-counter, proton pump inhibitors (PPIs) are a particularly strong class of medication used to treat gastroesophageal reflux disease (GERD), 频繁的心痛, 溃疡, esophagitis and other conditions arising from an over-production of stomach acid. 然而, PPIs have been linked to serious injuries including acute interstitial nephritis, chronic kidney disease, kidney failure and other serious, debilitating effects which may result in hospitalization or, 可悲的是, 甚至死亡.
Hundreds of lawsuits have been filed in the U.S. against PPI manufacturers, alleging effects caused by the drugs. Many plaintiffs claim that manufacturers continue to promote the use of the drugs without proper warning, and that had they known they risks they would not have taken PPIs.
Contact a Medical Drug Attorney
If you or a loved one took a PPI medication to reduce stomach acid and suffered severe injuries including chronic kidney disease, an acute kidney injury, 肾功能衰竭, or acute interstitial nephritis, you may have a claim. 联系律师 丹尼尔Lapinski by 电子邮件 或者拨打1.800.768.4026 to for more information or to discuss your potential claim.
Proton Pump Inhibitors Side Effects
2014年12月, FDA要求的 that warning labels be included on prescription PPIs to explain the risk of developing acute interstitial nephritis, a dangerous swelling of the kidneys that could lead to damage, “at any point during PPI therapy.此外, 研究 超过250个,000 patients published in January 2016 in the Journal of the American Medical Association (JAMA) found that those taking PPIs were 20 percent to 50 percent more likely to develop chronic kidney disease compared to those who were not on these medications.
Signs of kidney disease and failure may include:
- Too much or not enough urine leaving the body
- Swelling in legs, feet ankles and around the eyes
- Fatigue or tiredness
- 呼吸急促(气促)
- 肌肉痉挛
- 恶心和呕吐
- Seizures or coma in severe cases
- Back or abdominal pain or pressure
- 流鼻血
- 皮疹
- 死亡
质子泵抑制剂的背景
The FDA first approved prescription PPIs in 1989 and they have since grown into the most widely used class of prescription and over-the-counter drugs in the country. PPIs have been marketed by several pharmaceutical companies over the years, including Abbott Laboratories, 阿斯利康, 葛兰素史克公司, 默克公司, 诺华制药, 宝洁公司 & Gamble, Pfizer, Takeda, TAP Pharmaceutical and Wyeth.
Common brand-name PPI medications include:
- Prevacid® 和Prevacid® 24HR
- 奥美拉唑® 和奥美拉唑® 场外
- 埃索美拉唑® 和埃索美拉唑® 24HR
- Dexilant
- Protonix®
Our Medical Drug Litigation Experience
五颜六色的大米 medical attorneys have extensive experience litigating for patients who have suffered severe adverse effects and complications caused by dangerous prescription and over-the-counter drugs. We understand that as a patient or family member, your familiarity with medications you have been prescribed, and knowledge of potential risks, 可能是有限的. Our attorneys have the resources needed to thoroughly investigate and identify potentially harmful products, 医疗因果关系, compliance with FDA regulations, alleged inadequacy of warnings, alleged wrongdoing and other factors that could affect your potential claim.
In addition to reviewing potential PPI cases, our attorneys have represented clients in several medical drug cases, including diabetes drugs Januvia®, Victoza®, Janumet®, and Byetta®; chemotherapy drug 泰索帝®; gout medication Uloric®; MS medication Zinbryta®; and nausea medication 枢复宁®.
Do not stop taking a prescribed medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor's advice can result in injury or death.
五颜六色的大米有限公司, a South Carolina Limited Liability Company, is engaged in the New Jersey practice of law through 五颜六色的大米 New Jersey LLC. Esther Berezofsky attorney responsible for New Jersey practice.